SLC22A3 and hepatocellular carcinoma: Interestingly, OCT3 expression is relatively low in human hepatocytes and hepatoma cell lines as compared to OCT1, while OCT2, the previously reported cisplatin transporter of kidney, is missing in these cells [25].